Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

InflaRx N.V. - Common Stock (NQ:IFRX)

1.510 +0.340 (+29.06%)
Streaming Delayed Price Updated: 12:12 PM EDT, Aug 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about InflaRx N.V. - Common Stock

< Previous 1 2 3 4 5 Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time to dive into the biggest pre-market stock movers for Friday with all the shares investors will want to keep an eye on today! 
Via InvestorPlace
Why Oncorus Shares Are Trading Lower By 25%; Here Are 20 Stocks Moving Premarket
Gainers Auddia Inc. (NASDAQ: AUUD) shares rose 103.2% to $0.8809 in pre-market trading after gaining around 9% on Friday. 
Via Benzinga
The Week In Charts: 0DTE Options - Too Good To Be True?
Zero-days; how Core Methodology can be used in Crypto, with current Crypto and stock market conditions; favorite stock picks. 
Via Talk Markets
Apogee Enterprises, Sportsman's Warehouse And 3 Stocks To Watch Heading Into Wednesday
With US futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Why InflaRx Stock Skyrocketed This Week
The biopharmaceutical company's near-term sales outlook has gotten a huge boost following Emergency Use Authorization for one of its drugs. 
Via The Motley Fool
Analyst Expectations for InflaRx's Future
 
Via Benzinga
Post-Pandemic Potential: Analysts Eye InflaRx COVID-19 Antibody For Market Breakthrough
 
Via Benzinga
Walmart To Rally 14%? Here Are 10 Other Analyst Forecasts For Thursday
Keybanc boosted the price target for Walmart Inc. (NYSE: WMT) from $165 to $170. Keybanc analyst Bradley Thomas maintained an Overweight rating on the stock. Walmart shares fell 0.2% to $149.37 in... 
Via Benzinga
Dow Rises 80 Points; MarketAxess Holdings Shares Slide
U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 80 points on Wednesday. The Dow traded up 0.24% to 33,482.53 while the NASDAQ fell 1.21% to 11,979.98. The S&P 500,... 
Via Benzinga
Stocks Mixed As Investors Continue To Weigh Jobs Data
The Dow Jones Industrial Average has made its way into positive territory midday, though the S&P 500 Index and Nasdaq Composite are still swimming in the red. 
Via Talk Markets
Why Shares of InflaRx Are Soaring Wednesday
A key EUA from the FDA for the company's COVID-19 therapy gave the stock a jolt. 
Via The Motley Fool
InflaRx Scores FDA Emergency Use Nod For COVID Antibody
 
Via Benzinga
What 5 Analyst Ratings Have To Say About InflaRx
  InflaRx (NASDAQ:IFRX) has observed the following analyst ratings within the last quarter: 
Via Benzinga
InflaRx: Q2 Earnings Insights
  InflaRx (NASDAQ:IFRX) reported its Q2 earnings results on Friday, August 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings InflaRx reported EPS of $0.01. 
Via Benzinga
Why Kura Sushi Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 104% to $5.55 after the company announced it has been selected by the U.S. Department of Defense for a position on the multiple award Indefinite... 
Via Benzinga
Inflarx NV (NASDAQ: IFRX) is One of Wednesday Morning’s Most Active Stocks
Via Investor Brand Network
Nasdaq Tumbles 150 Points; Liminal BioSciences Shares Spike Higher
U.S. stocks traded mostly lower midway through trading, with the Nasdaq Composite dropping around 150 points on Wednesday. The Dow traded up 0.07% to 33,425.80 while the NASDAQ fell 1.27% to 11,972.78.... 
Via Benzinga
InflaRx Shares Are Flying Higher After Emergency Use Nod Plans For Its COVID-19 Treatment
 
Via Benzinga
Why Is InflaRx (IFRX) Stock Up 40% Today?
Today's news that InflaRx plans to apply for FDA emergency-use authorization for its Covid-19 treatment has IFRX stock surging. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For April 5, 2023
 
Via Benzinga
Why Is Liminal Biosciences (LMNL) Stock Up 77% Today?
Liminal Biosciences (LMNL) stock is taking off on Wednesday as investors react to the company getting an unsolicited transaction proposal. 
Via InvestorPlace
FDX Stock: What to Know as FedEx Consolidates Operating Companies
FedEx (FDX) stock is on the move Wednesday after the company announced plans to consolidate some of its operating companies. 
Via InvestorPlace
MorphoSys, Nuburu And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded mixed, with the Dow Jones gaining more than 50 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
InflaRx (IFRX) Stock Pops as FDA Grants Emergency Use Authorization
InflaRx (IFRX) stock is getting a boost on Wednesday following an update from the FDA concerning its Covid-19 treatment. 
Via InvestorPlace
Markets Mixed; US Trade Deficit Widens In February
U.S. stocks traded mixed this morning, with the Nasdaq Composite dropping more than 50 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.13% to 33,446.10 while the NASDAQ... 
Via Benzinga
Why Chicken Soup For The Soul Entertainment Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
Gainers RiceBran Technologies (NASDAQ: RIBT) gained 43.1% to $1.33 in pre-market trading after gaining 3% on Tuesday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're starting off Wednesday with a breakdown of the biggest pre-market stock movers traders need to know about this morning! 
Via InvestorPlace
InflaRx Receives FDA Emergency Use Authorization for Gohibic (vilobelimab) for Treatment of Critically Ill COVID-19 Patients
From InflaRx N.V.
Via GlobeNewswire
This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday
Gainers Getty Images Holdings, Inc. (NYSE: GETY) shares climbed 149.1% to close at $26.15 on Friday following its merger with special-purpose acquisition company (SPAC) CC Neuberger Principal Holdings... 
Via Benzinga
Why This Biotechnology Surged More Than 60%; Here Are 67 Biggest Movers From Yesterday
Gainers Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA) shares surged 94.3% to close at $1.69 on Tuesday after the company filed a request for the withdrawal of the Registration Statement on Form S-1. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.